-2%
Indacaterol + Glycopyrronium 110 mcg+50 mcg,Â
Recommended dose: One capsule inhaled once daily using the inhaler device
- Administer at the same time each day for optimal benefit
- If a dose is missed, take it as soon as possible on the same day
- Do not exceed more than one dose per day
- Hepatic impairment: Use with caution in severe cases; safe in mild to moderate impairment
- Renal impairment: Use cautiously in severe renal dysfunction; benefit-risk should be evaluated
- Children: Safety and efficacy not established (not recommended under 18 years)
Important:
- For inhalation use only; capsules must not be swallowed
- Correct inhaler technique is essential for effectiveness
Dilbro UniCap is indicated as a bronchodilator therapy for the symptomatic management of chronic obstructive pulmonary disease (COPD). It helps improve airflow by relaxing airway muscles, thereby easing breathing and reducing symptoms such as cough, wheezing, and shortness of breath.
Dilbro UniCap contains a combination of two active agents:
- Indacaterol: A long-acting β2-agonist (LABA) that stimulates adenyl cyclase, increasing cyclic AMP levels and resulting in relaxation of bronchial smooth muscle.
- Glycopyrronium: A long-acting muscarinic antagonist (LAMA) that blocks acetylcholine activity, leading to bronchodilation and reduced airway secretions.
Together, they enhance airway opening and improve respiratory function.